Literature DB >> 7599814

Arterial oxygenation time after an FIO2 increase in mechanically ventilated patients.

S A Sasse1, M B Jaffe, P A Chen, K G Voelker, C K Mahutte.   

Abstract

The time for arterial PO2 to reach equilibrium after a 0.2 increase in the fraction of inspired oxygen (FIO2) was studied, using arterial blood gases measured at 1, 2, 3, 4, 5, 7, 9, and 11 min in 30 stable, mechanically ventilated medical intensive care unit (ICU) patients. Eight patients also underwent a 0.4 increase in FIO2. Each patient's rise in PO2 over time [PO2(t)] was fit to the following exponential equation: PO2(t) = PO2i + (PO2f-PO2i) (1-e-kt), where t refers to time, PO2i and PO2f refer to the initial and final equilibrated PO2. The time constant k and PO2f were determined by a nonlinear curve fitting technique. The 90% oxygenation times (t90%), defined as the time required to reach 90% of the final equilibrated PO2, were calculated. The mean t90% (+/- SD) was 6.0 (+/- 3.4) min for all patients (range 1.7 to 14.3 min); 7.1 +/- 2.1 min for 18 patients with chronic obstructive pulmonary disease (COPD) and 4.4 +/- 2.0 min for 12 patients without COPD (p < 0.05). In the subgroup of patients undergoing both an FIO2 increase of 0.2 and 0.4, there was no significant difference in the mean t90%'s for the two FIO2 changes (7.7 versus 7.7 min). We conclude that after a 0.2 or 0.4 increase of FIO3, a 15-min equilibration time period is adequate for 90% of the increase in PO2 to occur, in stable, mechanically ventilated medical ICU patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7599814     DOI: 10.1164/ajrccm.152.1.7599814

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Time to reach a new steady state after changes of positive end expiratory pressure.

Authors:  D Chiumello; S Coppola; S Froio; C Mietto; L Brazzi; E Carlesso; L Gattinoni
Journal:  Intensive Care Med       Date:  2013-06-06       Impact factor: 17.440

2.  The accuracy of postoperative, non-invasive Air-Test to diagnose atelectasis in healthy patients after surgery: a prospective, diagnostic pilot study.

Authors:  Carlos Ferrando; Carolina Romero; Gerardo Tusman; Fernando Suarez-Sipmann; Jaume Canet; Rosa Dosdá; Paola Valls; Abigail Villena; Ferran Serralta; Ana Jurado; Juan Carrizo; Jose Navarro; Cristina Parrilla; Jose E Romero; Natividad Pozo; Marina Soro; Jesús Villar; Francisco Javier Belda
Journal:  BMJ Open       Date:  2017-05-29       Impact factor: 2.692

3.  Evaluation of time courses of agreement between minutely obtained transcutaneous blood gas data and the gold standard arterial data from spontaneously breathing Asian adults, and various subgroup analyses.

Authors:  Akira Umeda; Masahiro Ishizaka; Masamichi Tasaki; Tateki Yamane; Taiji Watanabe; Yasushi Inoue; Taichi Mochizuki; Yasumasa Okada; Sarah Kesler
Journal:  BMC Pulm Med       Date:  2020-05-29       Impact factor: 3.317

4.  Duration of sweep gas off trial for weaning from venovenous extracorporeal membrane oxygenation.

Authors:  Soo Jin Na; Hee Jung Choi; Chi Ryang Chung; Yang Hyun Cho; Kiick Sung; Jeong Hoon Yang; Gee Young Suh; Joong Hyun Ahn; Keumhee C Carriere; Kyeongman Jeon
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

5.  The Association between Mortality and the Oxygen Saturation and Fraction of Inhaled Oxygen in Patients Requiring Oxygen Therapy due to COVID-19-Associated Pneumonia.

Authors:  Keum-Ju Choi; Hyo-Lim Hong; Eun Jin Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2020-12-28

6.  Standardizing PaO2 for PaCO2 in P/F ratio predicts in-hospital mortality in acute respiratory failure due to Covid-19: A pilot prospective study.

Authors:  Irene Prediletto; Letizia D'Antoni; Paolo Carbonara; Federico Daniele; Roberto Dongilli; Roberto Flore; Angela Maria Grazia Pacilli; Lara Pisani; Corina Tomsa; María Laura Vega; Vito Marco Ranieri; Stefano Nava; Paolo Palange
Journal:  Eur J Intern Med       Date:  2021-06-17       Impact factor: 7.749

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.